Gender‐based outcomes of impeller pumps percutaneous ventricular assist devices

Background There is paucity of data focusing on females' outcomes after the use of impeller pumps percutaneous ventricular assist devices (IPVADs). Methods Patients who received IPVADs during the period of October 1st, 2015‐December 31, 2017, were identified from the United States National Read...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2021-04, Vol.97 (5), p.E627-E635
Hauptverfasser: Osman, Mohammed, Syed, Moinuddin, Abdul Ghaffar, Yasir, Patel, Brijesh, Abugroun, Ashraf, Kheiri, Babikir, Kawsara, Akram, Kadiyala, Madhavi, Balla, Sudarshan, Daggubati, Ramesh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background There is paucity of data focusing on females' outcomes after the use of impeller pumps percutaneous ventricular assist devices (IPVADs). Methods Patients who received IPVADs during the period of October 1st, 2015‐December 31, 2017, were identified from the United States National Readmission Database. A 1:1 propensity score matching was used to compare the outcomes between females and males. Results A total of 19,278 (Female = 5,456; Male = 13,822) patients were included in the current analysis. After propensity score matching and among all‐comers who were treated with IPVADs, females had higher in‐hospital major adverse events (MAEs) (38 vs. 32.6%, p 
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.29222